325 related articles for article (PubMed ID: 23109125)
21. Declining differences in response rates with antidepressants versus placebo: a modest proposal for another contributing cause.
Preskorn SH
J Psychiatr Pract; 2013 May; 19(3):227-33. PubMed ID: 23653079
[TBL] [Abstract][Full Text] [Related]
22. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries.
Rihmer Z; Akiskal H
J Affect Disord; 2006 Aug; 94(1-3):3-13. PubMed ID: 16712945
[TBL] [Abstract][Full Text] [Related]
23. Antidepressants: bitter pills.
Check E
Nature; 2004 Sep; 431(7005):122-4. PubMed ID: 15356601
[No Abstract] [Full Text] [Related]
24. Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression.
Valluri S; Zito JM; Safer DJ; Zuckerman IH; Mullins CD; Korelitz JJ
Med Care; 2010 Nov; 48(11):947-54. PubMed ID: 20856141
[TBL] [Abstract][Full Text] [Related]
25. Suicide prevention and serotonergic drugs.
Montgomery SA
Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():83-5. PubMed ID: 8201249
[TBL] [Abstract][Full Text] [Related]
26. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
[TBL] [Abstract][Full Text] [Related]
27. Health care consequences of black-box warnings for antidepressants in the United States and Canada.
Nagar S; Mehta S; Bhatara V; Aparasu R
Res Social Adm Pharm; 2010 Mar; 6(1):78-84. PubMed ID: 20188331
[No Abstract] [Full Text] [Related]
28. [Medical treatment of depression in children and adolescents].
Kölch M; Fegert JM
Prax Kinderpsychol Kinderpsychiatr; 2007; 56(3):224-33. PubMed ID: 17451152
[TBL] [Abstract][Full Text] [Related]
29. Antidepressants, suicide, and the FDA: a loose association.
Finley PR
Ann Pharmacother; 2004 Oct; 38(10):1739-42. PubMed ID: 15340125
[No Abstract] [Full Text] [Related]
30. Antidepressants and side effects.
Carter G
Aust N Z J Psychiatry; 1995 Jun; 29(2):337. PubMed ID: 7487802
[No Abstract] [Full Text] [Related]
31. Selective serotonin reuptake inhibitors and suicidality: a guide for the perplexed.
Brent DA
Can J Psychiatry; 2009 Feb; 54(2):72-4; discussion 75. PubMed ID: 19254435
[No Abstract] [Full Text] [Related]
32. The "black box" controversy.
Regan J; DeWire M; Whitby B; Bess T; Wright A
Tenn Med; 2005 Jan; 98(1):41-2. PubMed ID: 15696821
[No Abstract] [Full Text] [Related]
33. SSRIs, suicide and violent behavior: is there a need for a better definition of the depressive state?
Henry C; Demotes-Mainard J
Curr Drug Saf; 2006 Jan; 1(1):59-62. PubMed ID: 18690915
[TBL] [Abstract][Full Text] [Related]
34. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets.
Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Mann JJ
Am J Psychiatry; 2007 Jul; 164(7):1044-9. PubMed ID: 17606656
[TBL] [Abstract][Full Text] [Related]
35. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS
Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637
[TBL] [Abstract][Full Text] [Related]
36. Antidepressants and the FDA's black-box warning: determining a rational public policy in the absence of sufficient evidence.
Ho D
Virtual Mentor; 2012 Jun; 14(6):483-8. PubMed ID: 23351264
[No Abstract] [Full Text] [Related]
37. Treatment of major depression in adolescents: weighing the evidence of risk and benefit in light of black box warnings.
Lovrin M
J Child Adolesc Psychiatr Nurs; 2009 May; 22(2):63-8. PubMed ID: 19490276
[TBL] [Abstract][Full Text] [Related]
38. Withdrawal of attention rather than pharmacological treatment affects suicide rates in depressed children and adolescents.
Wohlfarth T; Boer F; van den Brink W
Am J Psychiatry; 2007 Dec; 164(12):1908; author reply 1908-10. PubMed ID: 18056249
[No Abstract] [Full Text] [Related]
39. Lost in the black box: juvenile depression, suicide, and the FDA's black box.
Rappaport N; Prince JB; Bostic JQ;
J Pediatr; 2005 Dec; 147(6):719-20. PubMed ID: 16356415
[No Abstract] [Full Text] [Related]
40. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
